4//SEC Filing
Arbet-Engels Christophe 4
Accession 0001209191-20-032486
CIK 0001544227other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 9:38 PM ET
Size
5.8 KB
Accession
0001209191-20-032486
Insider Transaction Report
Form 4
Arbet-Engels Christophe
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-05-25+80,000→ 80,000 totalExercise: $2.00Exp: 2030-05-24→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the remaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date.
Documents
Issuer
Millendo Therapeutics, Inc.
CIK 0001544227
Entity typeother
Related Parties
1- filerCIK 0001802615
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 9:38 PM ET
- Size
- 5.8 KB